Showing results (321-330 of 436) with videos related to
Sort By:
Pageof 44
Nature Communications|August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory statesLeo Rasche, Carolina Schinke, Francesco Maura, et al.JCO Precision Oncology|February 2, 2019
Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics ApproachAlessandro Laganà, Itai Beno, David Melnekoff, et al.Blood|May 7, 2015
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myelomaJeffrey R Sawyer, Erming Tian, Christoph J Heuck, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)Angela M Davies, Kari Chansky, Primo N Lara, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung CancerFrank C Detterbeck, Kari Chansky, Patti Groome, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Dementia Care Research and Psychosocial FactorsJohn Crowley, Kathleen Cahill, Sherril B Gelmon, et al.Blood|February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorAnne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.Oncotarget|April 22, 2017
The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myelomaCaleb K Stein, Charlotte Pawlyn, Shweta Chavan, et al.Pageof 44